Azenta, Inc. Acquires Ziath, Ltd.

Azenta Completes Sale of B Medical Systems to Thelema S.à r.l.

July 9, 2026

Medical Devices

Azenta has completed the sale of its B Medical Systems business to Thelema S.à r.l., closing the transaction on July 1, 2026 after all required conditions were satisfied. Azenta sold B Medical Systems for a fixed $63 million in cash, with $35 million financed through a short-term secured vendor loan provided by an Azenta subsidiary to Thelema.

Azenta Acquires UK Biocentre Limited to Expand European Biorepository Capabilities

March 6, 2026

Healthcare Services

Azenta, via its wholly owned subsidiary Azenta UK Ltd, acquired UK Biocentre Limited for £20.5 million (net of cash), including up to £1.8 million in contingent milestone consideration. The acquisition expands Azenta’s UK and broader European sample management, storage, and high-throughput processing capabilities, with UK Biocentre intended to serve as a European operational hub supporting life sciences customers.

AstraZeneca to Acquire EsoBiotec

March 18, 2025

Biotechnology

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company developing in vivo cell therapies. The deal is valued at up to $1 billion on a cash and debt-free basis, with an initial $425 million payment upon closing plus up to $575 million in contingent milestone consideration. The transaction is expected to close in Q2 2025, subject to regulatory approvals.

Bruker Corporation Acquires ZONTAL Inc.

May 8, 2023

Software

Bruker Corporation has closed the acquisition of ZONTAL Inc., a provider of a GxP-compliant life-sciences data platform, to strengthen Bruker BioSpin's Integrated Data Solutions (IDS) software portfolio. The deal (terms not disclosed) will integrate ZONTAL's vendor-agnostic laboratory and process data management capabilities with Bruker's Mestrelab, Arxspan and Optimal offerings to accelerate digital laboratory transformation for biopharma and life-science customers; ZONTAL expected 2023 revenues of greater than $5 million.

Trinity Consultants Acquires Aztec Technologies (and Aztec Process Automation Pvt. Ltd.)

March 14, 2022

Engineering Services

Trinity Consultants has acquired Aztec Technologies in the United States and Aztec Process Automation Pvt. Ltd. in India. The acquisition expands Trinity's engineering and industrial automation capabilities for life sciences clients, integrating Aztec's automation, data analytics, panel design and fabrication expertise with Trinity's life-science engineering solutions.

Arranta Bio Acquires Captozyme

November 13, 2019

Biotechnology

Arranta Bio has acquired Captozyme and integrated its Gainesville, Florida team and facilities to create a Center of Excellence for microbiome process and analytical development and early clinical supply. The acquisition expands Arranta's CDMO capabilities for live biotherapeutics and transfers Captozyme's clinical GMP capacity while Captozyme's enzyme therapeutic assets were spun out into Oxidien Pharmaceuticals.